home / stock / trib / trib news


TRIB News and Press, Trinity Biotech plc From 03/29/21

Stock Information

Company Name: Trinity Biotech plc
Stock Symbol: TRIB
Market: NASDAQ
Website: trinitybiotech.com

Menu

TRIB TRIB Quote TRIB Short TRIB News TRIB Articles TRIB Message Board
Get TRIB Alerts

News, Short Squeeze, Breakout and More Instantly...

TRIB - HGEN, CLDX, TBLT and TRIB among midday movers

Gainers: Humanigen (HGEN) +81%.Universe Pharmaceuticals (UPC) +70%.SeaChange International (SEAC) +60%.Elite Education Group International (EEIQ) +34%.Cyanotech (CYAN) +34%.Fly Leasing (FLY) +27%.Trinity Biotech (TRIB) +25%.Virpax Pharmaceuticals (VRPX) +21%.Hall of Fame Resort & Ent...

TRIB - Trinity Biotech plc (TRIB) CEO Ronan O'Caoimh on Q4 2020 Results - Earnings Call Transcript

Trinity Biotech plc (TRIB) Q4 2020 Results Conference Call March 26, 2021 11:00 AM ET Company Participants Ronan O’Caoimh - CEO John Gillard - CFO Conference Call Participants Jim Sidoti - Sidoti & Company Presentation Operator Good day, and welcome to the Trinity Biotech Q4 and Fi...

TRIB - Trinity Biotech EPS misses by $0.45, beats on revenue

Trinity Biotech (TRIB): Q4 Non-GAAP EPS of $0.36; GAAP EPS of -$0.31 misses by $0.45.Revenue of $32.8M (+53.8% Y/Y) beats by $4.8M.Shares -0.96%.Press Release For further details see: Trinity Biotech EPS misses by $0.45, beats on revenue

TRIB - Trinity Biotech Announces Quarter 4 and Fiscal Year 2020 Financial Results

DUBLIN, Ireland, March 25, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2020 and fiscal year 2020. ...

TRIB - Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2020 Financial Results

DUBLIN, Ireland, March 23, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2020 on Thursday, M...

TRIB - A Treatise On Trinity Biotech

Today, we offer up investment analysis on a little covered medical diagnostic name called Trinity Biotech. The company navigated the COVID-19 cross currents in 2020 as demand from the pandemic boosted sales. We take a quick look at and offer up our investment take on this 'off the...

TRIB - Trinity Biotech's COVID-19 antibody test OK'd in Europe

Trinity Biotech (TRIB) gains 10% in premarket after receiving CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia SARS-CoV-2 IgG ELISA.The test uses a recombinant form of coronavirus spike protein to detect IgG antibodies, the detection of whi...

TRIB - Trinity Biotech Announces CE Mark of its Covid-19 IgG ELISA Antibody Test

DUBLIN, Ireland, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia™ SARS-CoV-2 IgG ELISA. Trinity Biotech has launched the test in countries throughout the Eur...

TRIB - Top NASDAQ Biotech Stocks of 2020

Click here to read the previous top NASDAQ biotech stocks article. It’s been a stellar year for the NASDAQ Biotechnology Index (INDEXNASDAQ: NBI ), which started at 3,763.05 points in January and reached a high of 4,811.03 points on December 15. While the inde...

TRIB - Medigus, 180 Life Sciences leads healthcare gainers; Bellerophon Therapeutics, BioLineRx among major losers

Gainers: Medigus (MDGS) +36%, 180 Life Sciences (ATNF) +35%, Graybug Vision (GRAY) +23%, Trinity Biotech (TRIB) +18%, Accuray (ARAY) +14%.Losers: Bellerophon Therapeutics (BLPH) -18%, BioLineRx (BLRX) -13%, AIM ImmunoTech (AIM) -11%, iBio...

Previous 10 Next 10